Logo image of LTH.CA

LITHIUM IONIC CORP (LTH.CA) Stock Fundamental Analysis

Canada - TSX-V:LTH - CA53680V1076 - Common Stock

0.75 CAD
-0.04 (-5.06%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, LTH scores 1 out of 10 in our fundamental rating. LTH was compared to 805 industry peers in the Metals & Mining industry. Both the profitability and financial health of LTH have multiple concerns. LTH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year LTH has reported negative net income.
LTH had a negative operating cash flow in the past year.
LTH.CA Yearly Net Income VS EBIT VS OCF VS FCFLTH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

LTH has a Return On Assets (-36.90%) which is in line with its industry peers.
Industry RankSector Rank
ROA -36.9%
ROE N/A
ROIC N/A
ROA(3y)-218.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LTH.CA Yearly ROA, ROE, ROICLTH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500

1.3 Margins

LTH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LTH.CA Yearly Profit, Operating, Gross MarginsLTH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, LTH has more shares outstanding
LTH has a better debt/assets ratio than last year.
LTH.CA Yearly Shares OutstandingLTH.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
LTH.CA Yearly Total Debt VS Total AssetsLTH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

LTH has an Altman-Z score of -2.85. This is a bad value and indicates that LTH is not financially healthy and even has some risk of bankruptcy.
LTH has a worse Altman-Z score (-2.85) than 65.47% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.85
ROIC/WACCN/A
WACCN/A
LTH.CA Yearly LT Debt VS Equity VS FCFLTH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

LTH has a Current Ratio of 4.28. This indicates that LTH is financially healthy and has no problem in meeting its short term obligations.
LTH has a Current ratio of 4.28. This is in the better half of the industry: LTH outperforms 69.05% of its industry peers.
LTH has a Quick Ratio of 4.28. This indicates that LTH is financially healthy and has no problem in meeting its short term obligations.
LTH's Quick ratio of 4.28 is fine compared to the rest of the industry. LTH outperforms 69.67% of its industry peers.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.28
LTH.CA Yearly Current Assets VS Current LiabilitesLTH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

1

3. Growth

3.1 Past

LTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.04%, which is quite impressive.
EPS 1Y (TTM)78.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

LTH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.92% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y38.89%
EPS Next 2Y43.37%
EPS Next 3Y-11.57%
EPS Next 5Y18.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LTH.CA Yearly Revenue VS EstimatesLTH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 50M 100M 150M 200M
LTH.CA Yearly EPS VS EstimatesLTH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3 -0.4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LTH. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 72.82, LTH can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, LTH is valued cheaply inside the industry as 86.44% of the companies are valued more expensively.
LTH is valuated expensively when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 72.82
LTH.CA Price Earnings VS Forward Price EarningsLTH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LTH.CA Per share dataLTH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A cheap valuation may be justified as LTH's earnings are expected to decrease with -11.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.37%
EPS Next 3Y-11.57%

0

5. Dividend

5.1 Amount

LTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LITHIUM IONIC CORP

TSX-V:LTH (10/17/2025, 7:00:00 PM)

0.75

-0.04 (-5.06%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-20 2025-08-20
Earnings (Next)11-14 2025-11-14
Inst Owners12.89%
Inst Owner ChangeN/A
Ins Owners15.47%
Ins Owner ChangeN/A
Market Cap132.70M
Analysts84.62
Price Target3.86 (414.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.28%
PT rev (3m)-9.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)31.25%
EPS NY rev (3m)8.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 72.82
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)0.01
Fwd EY1.37%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.9%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-218.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6620.79%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.28
Quick Ratio 4.28
Altman-Z -2.85
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)579.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.87%
EPS Next Y38.89%
EPS Next 2Y43.37%
EPS Next 3Y-11.57%
EPS Next 5Y18.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.33%
EBIT Next 3Y36.92%
EBIT Next 5Y51.01%
FCF growth 1Y16.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.65%
OCF growth 3YN/A
OCF growth 5YN/A